Statistics

	Views
Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution	14

	Downloads
6807-30551.pdf	56

Select a period of time:

	Views
Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution	11

	Downloads
6807-30551.pdf	8

	Views
United States	11

	Downloads
United States	8

	Downloads
Ashburn	1

RUNA digital repository